Legal Representation
Attorney
Michael G. Shariff
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 13, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 13, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Sep 13, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| May 30, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 30, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 30, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 30, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 30, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 13, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, in the form of pills and liquid oral spray, for killing viruses, bacteria, coronaviruses including COVID-19, Monkeypox virus (MPV, MPXV, or hMPXV), biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; all purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and Monkeypox virus (MPV, MPXV, or hMPXV)
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005